Oregon State University receives $11.9 million from Defense Department to enhance health of armed forces
On Jan. 14, 2025, The U.S. Department of Defense (DoD) has awarded up to $11.9 million to Oregon…
Artificial Intelligence | Biotechnology | Diagnostics | Disease | Life Science News | Nanotechnology | Therapeutics
Virtual lab powered by ‘AI scientists’ super-charges life Science research
On Dec. 4, 2024, artificial intelligence (AI) researchers, in an effort to automate scientific discovery announced they have…
Nanorobot hand made of DNA grabs viruses for diagnostics and blocks cell entry
On Nov. 27, 2024, researchers at the University of Illinois Urbana-Champaign announced they had developed a nanorobotic hand…
Super microscope showed nanoscale biological process for the first time
On Nov. 12, 2024, researchers led by Nico Sommerdijk from Radboud university medical center in Nijmegen (Netherlands) announced…
Biotechnology | Chemical | Diagnostics | Disease | Environmental | Life Science News | Nanotechnology | Pharmaceutical | Therapeutics
Nanoplastics can reduce the effectiveness of antibiotics
On Oct. 30, 2024, an international research team led by the University of Bonn reported results of a…
Biotechnology | Diagnostics | Life Science News | Nanotechnology | Non-Profit Research | Therapeutics
KAIST Changes the Paradigm of Drug Discovery with World’s First Atomic Editing​
On Oct. 11, 2024, scientists at the Korea Advanced Institute of Science and Technology (KAIST) announced they had…
Biotechnology | Diagnostics | Environmental | Genomics | Infectious Disease | Life Science News | Medical Device | Nanotechnology | Oncology | Therapeutics | U.S. Congress
Strengthening the U.S. Biomedical Research Enterprise Entails National Strategic Coordination, Focus on Health Equity
On Oct. 1, 2024, the National Academy of Medicine (NAM) announced a study showing that although the U.S….
Diagnostics | Disease | Life Science News | Medical Device | Nanotechnology | Neurology | Non-Profit Research | Therapeutics
Imaging technique shows new details of peptide structures
On Apr. 26, 2024, engineers at Washington University in St. Louis announced a new imaging technique that give…
National Institutes of Health clinical trial of universal flu vaccine candidate began
On Sept. 15, 2023, researchers at the National Institute of Allergy and Infectious Diseases announced they had begun…
The Priestley Medal was awarded to Cato T. Laurencin
On Mar. 28, 2023, the American Chemical Society awarded The Priestley Medal to Cato T. Laurencin “to recognize distinguished…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Nanotechnology | Therapeutics | Vaccine
COVID-causing virus in air detected with high-tech bubbles
On Oct. 25, 2022, Pacific Northwest National Laboratory (PNNL) announced that scientists have shown that they can detect…
Novavax announced positive results of COVID-19 vaccine in pediatric population of PREVENT-19 phase 3 clinical trial
On Feb. 10, 2022, Novavax announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, achieved its primary effectiveness…
Novavax and Israel announced advance purchase agreement for supply of COVID-19 vaccine
On Jan. 28, 2022, Novavax and Israel’s Ministry of Health announced an agreement for the purchase of NVX-CoV2373,…
Novavax and Serum Institute filed for Emergency Use Authorization of Novavax’ COVID-19 vaccine in South Africa
On Jan. 10, 2022, Novavax and Serum Institute of India announced a regulatory submission to the South African…
Tonix Pharma announced exclusive collaboration with Kansas State University to develop LNP-Free mRNA vaccines
On Jan. 4, 2022, Tonix Pharmaceuticals announced an exclusive option agreement and research collaboration with Kansas State University…
Novavax and Serum Institute of India received Emergency Use Authorization for COVID-19 vaccine in India
On Dec. 28, 2021, Novavax and Serum Institute of India announced that the Drugs Controller General of India…
Novavax and SK bioscience announed expanded manufacturing agreement
On Dec. 23, 2021, Novavax and SK bioscience announced the expansion of the companies’ collaboration and license agreements…
Novavax announced initiation of PREVENT-19 COVID-19 vaccine phase 3 trial booster study
On Dec. 21, 2021, Novavax announced that the first booster doses of NVX-CoV2373, the company’s recombinant nanoparticle protein-based…
World Health Organization granted scond Emergency Use listing for Novavax COVID-19 vaccine
On Dec. 20, 2021, Novavax announced that the World Health Organization (WHO) had granted a second Emergency Use…
Novavax and Serum Institute of India announced WHO Emergency Use listing for NVX-CoV2373 COVID-19 vaccine
On Dec. 17, 2021, Novavax and SK bioscience announced that the World Health Organization (WHO) had granted Emergency…
Novavax announced submission of New Drug Application in Japan for approval of COVID-19 vaccine
On Dec. 15, 2021, Novavax announced the submission of a New Drug Application to the Ministry of Health,…
Llama antibodies could help fight SARS-CoV-2 variants
On Dec. 7, 2021, Rockefeller University scientists announced a study had demonstrated the therapeutic potential of an unusual…
Novavax and Serum Institute of India received Emergency Use Authorization for COVID-19 vaccine in the Philippines
On Nov. 17, 2021, Novavax and and Serum Institute of India announced that the Philippine Food and Drug…
Zosano Pharma announced successful formulation of COVID-19 vaccine candidate on its microneedle patch system
On Nov. 17, 2021, Zosano Pharma announced that the Philippine Food and Drug Administration had granted emergency use…
Novavax announced submission of Biologics License Application in South Korea for approval of NVX-CoV2373
On Nov. 15, 2021, Novavax and SK bioscience announced submission of a Biologics License Application (BLA) for Novavax’…
Leading Generic Drug Makers Unite to Pledge Capacity for Developing and Delivering Affordable COVID-19 Interventions as Pandemic Intensifies
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…
Novavax filed COVID-19 vaccine for Emergency Use listing with World Health Organization
On Nov. 4, 2021, Novavax announced the completion of its rolling submission to the World Health Organization (WHO)…
Novavax and Serum Institute of India receive Emergency Use Authorization for COVID-19 vaccine in Indonesia
On Nov. 1, 2021, Novavax and Serum Institute of India announced that the National Agency of Drug and…
Novavax and Serum Institute announced submission to WHO for Emergency Use Listing of COVID-19 vaccine
On Sept. 23, 2021, Novavax with its partner, Serum Institute of India announced a regulatory submission to the…
The Medicines Patent Pool secured its first licence for malaria, tuberculosis and hepatitis C
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…